Zobrazeno 1 - 10
of 62
pro vyhledávání: '"Vladimír, Soška"'
Autor:
Vladimír, Soška
Publikováno v:
Vnitřní lékařství. 68:191-194
PCSK9 inhibitors are modern and effective hypolipidemic drugs for lowering LDL-cholesterol, which belong to the#8222;biological therapy#8220;. Their prescription is limited to specialized centers and to the fulfillment of other conditions set by SÚK
Autor:
Peter Wohlfahrt, Renata Cífková, Narine Movsisyan, Šárka Kunzová, Jiří Lešovský, Martin Homolka, Vladimír Soška, Petr Dobšák, Francisco Lopez- Jimenez, Ondřej Sochor
Publikováno v:
Artery Research, Vol 20 (2017)
Objectives: Cardio-ankle vascular index (CAVI), a parameter of arterial stiffness, has been increasingly used for cardiovascular risk estimation. Currently used CAVI reference values are derived from the Japanese population. It is not clear whether t
Externí odkaz:
https://doaj.org/article/08058636aef94d69be5bf05b161458a4
Autor:
Vladimír Soška
Publikováno v:
Vnitrni lekarstvi. 68(1)
The concentration of total cholesterol has so far been part of the SCORE tables for estimating the risk of cardiovascular events; in the new SCORE2 tables, it has already been replaced by non-HDL-cholesterol. Total cholesterol continues to serve as a
Autor:
Vladimír Soška
Publikováno v:
Vnitřní lékařství. 67:37-40
Treatment of dyslipidemia and hypertension is a key step for reducing the risk of atherosclerotic cardiovascular disease. Dyslipidemia and hypertension often occur in one patient at the same time, so both of these risk factors need to be addressed at
Autor:
Ondřej Kyselák, Vladimír Soška
Publikováno v:
Vnitrni lekarstvi. 67(3)
In many patients it is difficult to achieve the current very low target LDL-cholesterol levels, recommended for the prevention of atherosclerotic cardiovascular events. If statin therapy or statins in combination with ezetimibe are not sufficient, ad
Autor:
Tomáš Freiberger, Vladimír Soška, Lukas Tichy, J. Kovar, Ondrej Kyselak, Jaroslav A. Hubacek, Hana Grombirikova
Publikováno v:
Journal of clinical lipidology. 15(3)
We describe the casuistry of a homozygous familial hypercholesterolemia female patient with a biallelic missense variant (NM_000527.4:c.1775G>A, p.Gly592Glu) in the LDLR gene, severe hypertriglyceridemia and late manifestation of coronary heart disea
Autor:
Vladimír Soška, Ondřej Kyselák
Publikováno v:
Vnitřní lékařství. 63:663-666
Statins are key drugs for patients in secondary prevention of cardiovascular disease, as well as for primary prevention patients at high or very high risk of fatal cardiovascular events. However, long-term compliance of patients to statin therapy is
Autor:
Jan Piťha, Pavel Kraml, Vladimír Soška, Zuzana Urbanová, Tomáš Štulc, Renata Cifkova, Vladimír Bláha, Hana Rosolová, David Karasek, Tomáš Freiberger, Michal Vrablík
Publikováno v:
Vnitrni lekarstvi. 64(12)
This article summarised opinion of the European Society for Atherosclerosis on the causal relationship between low density lipoprotein (LDL) and the development of atherosclerosis. The fact that there is a clear causal relationship between the LDL co
Autor:
Ondřej Kyselák, Vladimír Soška
Publikováno v:
Vnitrni lekarstvi. 64(10)
Statins are among the most important drugs in preventive cardiology because they greatly improve the prognosis of risk patients in both primary and secondary prevention of atherosclerotic cardiovascular disease. Adherence to long-term statin therapy
Autor:
Marie Nováková, Jirı́ Wotke, Yusuke Inoue, Petr Konecny, Veronika Mrkvicová, Petr Dobšák, Jaromir Vasku, Vladimír Soška, Michal Pohanka, Takashi Isoyama, Terumi Yurimoto, Petra Palanová, Yusuke Abe, Pavel Homolka, Itsuro Saito
Publikováno v:
Artificial Organs. 40:1137-1145
Histopathological analysis can provide important information in long-term experiments with total artificial heart (TAH). Recently, a new type of blood pump, the helical flow total artificial heart (HF-TAH) was developed. This study aimed to investiga